Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders.

Yang CW, Mousa SA.

Complement Ther Med. 2012 Dec;20(6):466-74. doi: 10.1016/j.ctim.2012.07.004. Epub 2012 Aug 17. Review.

PMID:
23131380
[PubMed - indexed for MEDLINE]
2.

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.

Hing Ling PK, Civeira F, Dan AG, Hanson ME, Massaad R, De Tilleghem Cle B, Milardo C, Triscari J.

Lipids Health Dis. 2012 Jan 31;11:18. doi: 10.1186/1476-511X-11-18.

PMID:
22293030
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pitavastatin: clinical effects from the LIVES Study.

Teramoto T.

Atheroscler Suppl. 2011 Nov;12(3):285-8. doi: 10.1016/S1567-5688(11)70888-1. Review.

PMID:
22152283
[PubMed - indexed for MEDLINE]
4.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
[PubMed - indexed for MEDLINE]
5.

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE.

JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649.

PMID:
22089718
[PubMed - indexed for MEDLINE]
6.

Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial.

Eriksson M, Budinski D, Hounslow N.

Adv Ther. 2011 Sep;28(9):811-23. doi: 10.1007/s12325-011-0056-7. Epub 2011 Aug 25.

PMID:
21874538
[PubMed - indexed for MEDLINE]
7.

Long-term efficacy of pitavastatin versus simvastatin.

Eriksson M, Budinski D, Hounslow N.

Adv Ther. 2011 Sep;28(9):799-810. doi: 10.1007/s12325-011-0057-6. Epub 2011 Aug 25.

PMID:
21874537
[PubMed - indexed for MEDLINE]
8.

Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.

Yoon HS, Kim SH, Kim JK, Ko SH, Ko JE, Park SJ, Park MG, Lee JH, Hyon MS.

Ann Pharmacother. 2011 Jul;45(7-8):841-9. doi: 10.1345/aph.1P511. Epub 2011 Jun 21. Erratum in: Ann Pharmacother. 2011 Sep;45(9):1172.

PMID:
21693699
[PubMed - indexed for MEDLINE]
9.

Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.

Farnier M, Steinmetz A, Retterstøl K, Császár A.

Clin Ther. 2011 Jan;33(1):1-12. doi: 10.1016/j.clinthera.2011.02.006.

PMID:
21397769
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.

Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G, Purpura L, Torres D, Campisi D.

Int Angiol. 2010 Dec;29(6):514-24.

PMID:
21173733
[PubMed - indexed for MEDLINE]
13.

Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.

Ramachandran S, Saraf S, Shetty C, Capps N, Bailey C.

Ann Clin Biochem. 2011 Jan;48(Pt 1):75-8. doi: 10.1258/acb.2010.010081. Epub 2010 Nov 29.

PMID:
21115572
[PubMed - indexed for MEDLINE]
14.

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P; IN-PRACTICE study.

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.

PMID:
20487050
[PubMed - indexed for MEDLINE]
15.

Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.

Lakoski SG, Xu F, Vega GL, Grundy SM, Chandalia M, Lam C, Lowe RS, Stepanavage ME, Musliner TA, Cohen JC, Hobbs HH.

J Clin Endocrinol Metab. 2010 Feb;95(2):800-9. doi: 10.1210/jc.2009-1952. Epub 2009 Dec 4. Erratum in: J Clin Endocrinol Metab. 2011 May;96(5):1582.

PMID:
19965915
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.

Abel T, Fehér J, Dinya E, Eldin MG, Kovács A.

Med Sci Monit. 2009 Dec;15(12):MS6-11.

PMID:
19946244
[PubMed - indexed for MEDLINE]
17.

Monotherapy vs combination therapy for dyslipidemia in the elderly.

Shepherd J.

Am J Geriatr Cardiol. 2008 Mar-Apr;17(2):108-13. Review.

PMID:
18326949
[PubMed - indexed for MEDLINE]
18.

Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study.

Laks T, Keba E, Leiner M, Merilind E, Petersen M, Reinmets S, Väli S, Sööt T, Otter K.

Vasc Health Risk Manag. 2008;4(6):1407-16.

PMID:
19337553
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].

Chen H, Ren JY, Wu B, Liu X, Wang RJ, Li LJ, Luo Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Jun;35(6):531-5. Chinese.

PMID:
17711713
[PubMed - indexed for MEDLINE]
20.

A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet.

Ose L, Johnson-Levonas A, Reyes R, Lin J, Shah A, Tribble D, Musliner T; Vytorin Extension Study Group.

Int J Clin Pract. 2007 Sep;61(9):1469-80. Epub 2007 Jul 26.

PMID:
17655686
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk